Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zonisamide-induced behavior disorder in two children

S Kimura1

  • 1Department of Pediatrics, Urafune Hospital of Yokohama City University School of Medicine, Japan.

Epilepsia
|March 1, 1994
PubMed
Summary

Zonisamide (ZNS) can cause behavior disorders in children, even at low doses. These adverse effects occurred in young patients without prior mental health issues, suggesting a direct link to ZNS treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway.

FEBS letters·1992
Same author

Prognostic factors in patients surviving for more than 1 or 5 years after removal of metastatic brain tumors.

Neurologia medico-chirurgica·1992
Same author

Molecular cloning and partial characterization of a novel collagen chain, alpha 1(XVI), consisting of repetitive collagenous domains and cysteine-containing non-collagenous segments.

Journal of biochemistry·1992
Same author

[Activity of Enterococcus faecalis (FK-23) preparation as a biological response modifier].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·1992
Same author

The effect of dietary safflower phospholipid on steroids in gastrointestinal tract of rats fed a hypercholesterolemic diet.

Journal of nutritional science and vitaminology·1992
Same author

Intraoperative echocardiography for diagnosis and treatment of aortic dissection. Utility of color flow mapping for surgical decision making in acute stage.

Herz·1992

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Zonisamide (ZNS) is an anticonvulsant medication used to treat epilepsy.
  • Previous reports linked ZNS to behavioral and psychotic disorders, but often in patients with complex partial seizures (CPS) on combination therapy (e.g., with phenytoin (PHT)).
  • The causal role of ZNS alone in inducing behavioral issues, particularly in younger patients, remained unclear.

Observation:

  • Two pediatric patients, a 1-year-old girl and a 3-year-old boy, developed behavioral disorders.
  • Neither patient had prior developmental or mental health problems.
  • Both patients experienced secondarily generalized motor seizures during ZNS treatment.

Findings:

  • The patients exhibited behavioral disorders despite having serum ZNS concentrations within or even below the established therapeutic range (8.8 and 12.3 µg/mL).
  • Unlike previous reports, these children did not have CPS or receive combination therapy, isolating ZNS as the likely causative agent.
  • This suggests Zonisamide can induce behavioral disturbances independently and at lower-than-expected levels.

Implications:

  • Zonisamide may induce behavioral disorders in pediatric patients even at sub-therapeutic or therapeutic serum concentrations.
  • Clinicians should monitor for behavioral changes in children treated with ZNS, irrespective of seizure type or concurrent medications.
  • These findings highlight the importance of considering ZNS as a potential cause of new-onset behavioral issues in pediatric epilepsy management.

Related Experiment Videos